Evidence map›Paper›PMID 26343538›Full record

ArticleNature immunology2015

Subversion of anticancer immunosurveillance by radiotherapy.

Laurence Zitvogel, Guido Kroemer

Abstract readComment
PubMed Publisher
In one paragraph

Article in Nature immunology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Radiotherapy and immunotherapy: a beneficial liaison?Nature reviews. Clinical oncology · 2017
    Review
  18. Molecular mechanisms involved in dendritic cell dysfunction in cancer.Cellular and molecular life sciences : CMLS · 2017
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Laurence Zitvogelthe Gustave Roussy Cancer Campus, Villejuif, France; Inserm U1015, Villejuif, France, Université Paris Sud-XI, Faculté de Médecine, Le Kremlin Bicêtre, France; and the Center of Clinical Investigations in Biotherapies of Cancer 507, Villejuif, France.
Guido KroemerEquipe 11 labellisée par la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Inserm U1138, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Université Pierre et Marie Curie, Paris, France; Pôle de Biologie, Hôpital Européen Georges Pompidou, Assistance Publiques-Hôpitaux de Paris, Paris, France; and Metabolomics and Cell Biology Platforms, Institut Gustave Roussy, Villejuif, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Radiation, IonizingAnimalsCyclin-Dependent Kinase Inhibitor p21Langerhans CellsT-Lymphocytes, RegulatoryCyclin-Dependent Kinase Inhibitor p21

Identifiers

PMID26343538

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.